Spots Global Cancer Trial Database for e7438
Every month we try and update this database with for e7438 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Study of Tazemetostat on Safety in Participants With Relapsed or Refractory Follicular Lymphoma With Enhancer of Zeste Homolog 2 (EZH2) Gene Mutation in Japan | NCT05228158 | Lymphoma, Folli... | Tazemetostat | - | Eisai Inc. | |
A Study of Tazemetostat in Participants With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma | NCT03009344 | Relapsed or Ref... | Tazemetostat | 20 Years - | Eisai Inc. | |
A Study of Tazemetostat on Safety in Participants With Relapsed or Refractory Follicular Lymphoma With Enhancer of Zeste Homolog 2 (EZH2) Gene Mutation in Japan | NCT05228158 | Lymphoma, Folli... | Tazemetostat | - | Eisai Inc. | |
A Study of Tazemetostat in Participants With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma | NCT03009344 | Relapsed or Ref... | Tazemetostat | 20 Years - | Eisai Inc. |